CYP2C19 polymorphisms in patients with gastric and colorectal carcinoma

International Journal of Gastrointestinal Cancer

Volumn 37, Issue 1, 2006, Pages 1-5

  Tamer, L ^a   Ercan, B ^a   Ercan, S ^a   Ates N ^a   Ates C ^b   Ocal K ^a   Dirlik, M ^a   Aydin, S ^a   Atik, U ^a  

^a MERSIN UNIVERSITY   (Turkey)

^b KOCAELI UNIVERSITY   (Turkey)

Author keywords

CYP2C19; Gastric and colorectal carcinomas; Polymorphism

Indexed keywords

CYTOCHROME P450 2C19;

ARTICLE; CANCER PATIENT; CANCER SUSCEPTIBILITY; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA ISOLATION; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOMA; TURKEY (REPUBLIC);

ARYL HYDROCARBON HYDROXYLASES; COLORECTAL NEOPLASMS; DNA, NEOPLASM; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE DETECTION; HUMANS; MALE; MIXED FUNCTION OXYGENASES; ODDS RATIO; POLYMORPHISM, GENETIC; SEX CHARACTERISTICS; STOMACH NEOPLASMS; XENOBIOTICS;

EID: 33846976475     PISSN: 15373649     EISSN: 15590739     Source Type: Journal    
DOI: 10.1385/IJGC:37:1:1     Document Type: Article

References (17)

1. Saadat I, Saadat M. Glutathione S-transferase M1 and T1 null genotypes and the risk of gastric and colorectal cancers. Cancer Lett 2001;169:21-26.
2. Modugno F, Knoll C, Kanbour-Shakir A, Romkes M. A potential role for the estrogen-metabolizing cytochrome P450 enzymes in human breast carcinogenesis. Breast Cancer Res Treat 2003;82:191-197.
3. Miller JA, Miller EC. Some historical aspects of N-aryl carcinogens and their metabolic activation. Environ Health Perspect 1983;49:3-12.
4. Nelson DR, Koymans L, Kamataki T, et al. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 1996; 6:1-42.
5. Xie HG, Kim RB, Wood AJ, Stein CM. Molecular basis of ethnic differences in drug disposition and response. Annu Rev Pharmacol Toxicol 2001;41:815-850.
6. Shi WX, Chen SQ. Frequencies of poor metabolizers of cytochrome P450 2C19 in esophagus cancer, stomach cancer, lung cancer and bladder cancer in Chinese population. World J Gastroenterol 2004;10:1961-1963.
7. Agundez JA. Cytochrome P450 gene polymorphism and cancer. Curr Drug Metab 2004;5:211-224.
8. Brockton N, Little J, Sharp L, Cotton SC. N-Acetyltransferase and colorectal cancer: a huge review. Am J Epidomiol 2000;151:846-881.
9. Rooney PH, Murray GI, Stevenson DA, Haites NE, Cassidy J, McLeod HL. Comparative genomic hybridization and chromosomal instability in solid tumours. Br J Cancer 1999;80:862-873.
10. Howson CP, Hiyama T, Wynder EL. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev 1986;8:1-27.
11. Katoh T, Boissy R, Nagata N, et al. Inherited polymorphism in the N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and susceptibility to gastric and colorectal adenocarcinoma. Int J Cancer 2000;85:46-49.
12. Suzuki S, Muroishi Y, Nakanishi I, Oda, Y. Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer. J Gastroenterol 2004,39:220-230.
13. Tanaka E: Update: genetic polymorphism of drug metabolizing enzymes in humans. J Clin Pharm Ther 1999;24: 323-329.
14. Wadelius M, Autrup JL, Stubbins MJ, et al. Polymorphisms in NAT2, CYP2D6, CYP2C19 and GSTP1 and their association with prostate cancer. Pharmacogenetics 1999;9: 333-340.
15. Roddam PL, Rollinson S, Kane E, et al. Poor metabolizers at the cytochrome P450 2D6 and 2C19 loci are at increased risk of developing adult acute leukaemia. Pharmacogenetic 2000;10:605-615.
16. Sachse C, Smith G, Wilkie MJ, et al. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis 2002;23: 1839-1849.
17. Chau TK, Marakami S, Kawai B, Nasu K, Kubota T, Ohnishi A. Genotype analysis of the CYP2C19 gene in HCVseropositive patients with cirrhosis and hepatocellular carcinoma. Life Sci 2000;67:1719-1724.